Whole Blood Chemiluminescence Immunoassay Analyzer Serum Plasma

Introduction

The platform CLIA-mate is a magnetic particle-based immunoassay system with ALP-AMPPD principle. It also combines the accuracy of CLIA technology with the flexibility and simplicity of POCT. The all-in-one design of reagent cartridge can reduce unnecessary waste,and comprehensive test panels concludes cardiac markers, inflammation markers, fertility, thyroid and so on, these make CLIA-mate an ideal system for clinical departments, clinics, hospital,laboratories and even a supplement in central labs.

CLIA-mate POCT Chemiluminescence Immunoassay analyzer--clinical analytical platform

Product parameters:

Easy operation

The procedures of operation are shown as the picture below:

• Understand how to use in 30min
• Totally free of maintenance
• 600 days MTBF

All-in-one reagent design

CLIA-mate

Advantages:

• Compact and Cost-effective
• Delicate Machine Design
• Easy to Use

Reaction modules

Piercing Module

Disposable Pipette Tips

Magnetic Module

Incubation Module

Position for used tips

Position for new tips

Test menu

Company profile

Aikang Group is a national high-tech company specialized in R&D, production, sales and service of medical devices. Founded in 2003, Aikang is headquartered in Shenzhen China and has established three R&D and production bases with a total area of 30,000 square meters and hundreds of employees.

The mission of Aikang is not only for China, but also for the world,and the vision is to be the leader in global medical automation.

Aikang has three Manufacture Bases:

Aikang MedTech Co., Ltd. , Aikang Diagnostic Co., Ltd. and Aisikang MedTech Co., Ltd. .